Dynamic chromatin accessibility licenses STAT5- and STAT6-dependent innate-like function of T H 9 cells to promote allergic inflammation

Allergic diseases are a major global health issue. Interleukin (IL)-9-producing helper T (T 9) cells promote allergic inflammation, yet T 9 cell effector functions are incompletely understood because their lineage instability makes them challenging to study. Here we found that resting T 9 cells prod...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature immunology 2023-06, Vol.24 (6), p.1036
Hauptverfasser: Son, Aran, Meylan, Francoise, Gomez-Rodriguez, Julio, Kaul, Zenia, Sylvester, McKella, Falduto, Guido H, Vazquez, Estefania, Haque, Tamara, Kitakule, Moses M, Wang, Chujun, Manthiram, Kalpana, Qi, Chen-Feng, Cheng, Jun, Gurram, Rama K, Zhu, Jinfang, Schwartzberg, Pamela, Milner, Joshua D, Frischmeyer-Guerrerio, Pamela A, Schwartz, Daniella M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Allergic diseases are a major global health issue. Interleukin (IL)-9-producing helper T (T 9) cells promote allergic inflammation, yet T 9 cell effector functions are incompletely understood because their lineage instability makes them challenging to study. Here we found that resting T 9 cells produced IL-9 independently of T cell receptor (TCR) restimulation, due to STAT5- and STAT6-dependent bystander activation. This mechanism was seen in circulating cells from allergic patients and was restricted to recently activated cells. STAT5-dependent Il9/IL9 regulatory elements underwent remodeling over time, inactivating the locus. A broader 'allergic T 9' transcriptomic and epigenomic program was also unstable. In vivo, T 9 cells induced airway inflammation via TCR-independent, STAT-dependent mechanisms. In allergic patients, T 9 cell expansion was associated with responsiveness to JAK inhibitors. These findings suggest that T 9 cell instability is a negative checkpoint on bystander activation that breaks down in allergy and that JAK inhibitors should be considered for allergic patients with T 9 cell expansion.
ISSN:1529-2916
DOI:10.1038/s41590-023-01501-5